Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 33303420)

  • 21. PEG-aspargase and DEP regimen combination therapy for refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
    Wang J; Wang Y; Wu L; Zhang J; Lai W; Wang Z
    J Hematol Oncol; 2016 Sep; 9(1):84. PubMed ID: 27613189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful treatment of hemophagocytic syndrome in a patient with T cell lymphoma, EBV infection, and bone marrow necrosis: A case report.
    Xu L; Liu X; Wang Y; Wang Y; Chu X; Chen L
    Medicine (Baltimore); 2022 Mar; 101(9):e28943. PubMed ID: 35244052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rituximab, etoposide, methylprednisolone, high-dose cytarabine, and cisplatin in the treatment of secondary hemophagocytic lymphohistiocytosis with classical Hodgkin lymphoma: a case report and review of the literature.
    Hu S; Bansal P; Lynch D; Rojas Hernandez CM; Dayao Z
    J Med Case Rep; 2016 Dec; 10(1):365. PubMed ID: 27998299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Profiling of EBV-Encoded microRNAs in EBV-Associated Hemophagocytic Lymphohistiocytosis.
    Zhou C; Xie Z; Gao L; Liu C; Ai J; Zhang L; Shen K
    Tohoku J Exp Med; 2015 Oct; 237(2):117-26. PubMed ID: 26423217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Rapid Cytologic Double Staining of Epstein-Barr Virus-encoded Small RNA and Cell Surface Markers for Diagnosis of Epstein-Barr Virus-associated Hemophagocytic Lymphohistiocytosis.
    Takahashi N; Kudo K; Tanaka M; Kumagai N; Sato T; Kamio T; Sasaki S; Terui K; Kurose A; Yanagisawa R; Nakazawa Y; Ito E
    J Pediatr Hematol Oncol; 2020 Nov; 42(8):e756-e758. PubMed ID: 31743316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved hemophagocytic lymphohistiocytosis index predicts prognosis of adult Epstein-Barr virus-associated HLH patients.
    Yao S; He L; Zhang R; Liu M; Hua Z; Zou H; Wang Z; Wang Y
    Ann Med; 2023 Dec; 55(1):89-100. PubMed ID: 36533966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epstein-Barr virus central nervous system involvement in Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
    Yin Q; Wang J; Wang Z
    Ann Hematol; 2022 Nov; 101(11):2471-2476. PubMed ID: 36071294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epstein-Barr Virus-associated Hemophagocytic Lymphohistiocytosis in Adults: A Retrospective Analysis of 23 Patients in China.
    Shao X; Xu Y; Xu X; Xu Y; Chen H; Hong M; Liu L
    Isr Med Assoc J; 2018 Feb; 20(2):80-85. PubMed ID: 29431300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Secondary hemophagocytic lymphohistiocytosis in pediatric patients with visceral leishmaniasis and Epstein-Barr virus infection.
    Li Y; Li S; Lu N; Wang W; Wang D
    Ann Hematol; 2024 May; 103(5):1541-1547. PubMed ID: 38467825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical features of adult patients with secondary hemophagocytic lymphohistiocytosis from causes other than lymphoma: an analysis of treatment outcome and prognostic factors.
    Park HS; Kim DY; Lee JH; Lee JH; Kim SD; Park YH; Lee JS; Kim BY; Jeon M; Kang YA; Lee YS; Seol M; Lee YJ; Lim YS; Jang S; Park CJ; Chi HS; Lee KH
    Ann Hematol; 2012 Jun; 91(6):897-904. PubMed ID: 22147006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spectrum and trigger identification of hemophagocytic lymphohistiocytosis in adults: A single-center analysis of 555 cases.
    Miao Y; Zhang J; Chen Q; Xing L; Qiu T; Zhu H; Wang L; Fan L; Xu W; Li J
    Front Immunol; 2022; 13():970183. PubMed ID: 36032133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment outcomes and prognostic analysis of 61 Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis].
    Zeng X; Wei N; Wang Y; Wang J; Zhang J; Wu L; Huang W; Gao Z; Pei R; Chen J; Jin Z; Wang Z
    Zhonghua Xue Ye Xue Za Zhi; 2015 Jun; 36(6):507-10. PubMed ID: 26134018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemophagocytic lymphohistiocytosis associated with Epstein-Barr virus-positive diffuse large B-cell lymphoma, NOS of bone marrow-liver-spleen type: an autopsy case report.
    Iizuka H; Mori Y; Iwao N; Koike M; Noguchi M
    J Clin Exp Hematop; 2021 Jun; 61(2):102-108. PubMed ID: 33994430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epstein-Barr virus viral load in human immunodeficiency virus-positive patients with reactive hemophagocytic syndrome.
    Boisseau M; Lambotte O; Galicier L; Lerolle N; Marzac C; Aumont C; Coppo P; Fardet L
    Infect Dis (Lond); 2015 Jun; 47(6):423-7. PubMed ID: 25746607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The superiority of Epstein-Barr virus DNA in plasma over in peripheral blood mononuclear cells for monitoring EBV-positive NK-cell lymphoproliferative diseases.
    Zheng M; Bao Y; Wang J; Ma Y; Yang Y; Zhang P; Chen L; Zheng K; Zhou J
    Hematol Oncol; 2022 Aug; 40(3):381-389. PubMed ID: 35405763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epstein-Barr virus (EBV)-induced B-cell proliferative disorder after chemotherapy in a patient with hemophagocytic lymphohistiocytosis with associated EBV-induced T-cell proliferation.
    Suzumiya J; Ohshima K; Kanda M; Kumagawa M; Nagano M; Hirata M; Nawa Y; Tamura K; Kikuchi M
    Leuk Lymphoma; 2000 May; 37(5-6):593-604. PubMed ID: 11042520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rituximab-containing immuno-chemotherapy regimens are effective for the elimination of EBV for EBV-HLH with only and mainly B lymphocytes of EBV infection.
    Meng GQ; Wang JS; Wang YN; Wei N; Wang Z
    Int Immunopharmacol; 2021 Jul; 96():107606. PubMed ID: 33826999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using etoposide + dexamethasone-based regimens to treat nasal type extranodal natural killer/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis.
    Wei L; Yang L; Cong J; Ye J; Li X; Yao N; Yang J; Ding J; Wang J
    J Cancer Res Clin Oncol; 2021 Mar; 147(3):863-869. PubMed ID: 33025280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nivolumab treatment of relapsed/refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adults.
    Liu P; Pan X; Chen C; Niu T; Shuai X; Wang J; Chen X; Liu J; Guo Y; Xie L; Wu Y; Liu Y; Liu T
    Blood; 2020 Mar; 135(11):826-833. PubMed ID: 31914172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemophagocytic Lymphohistiocytosis Secondary to Hodgkin's Lymphoma with Isolated Bone Marrow Involvement in a Newly Diagnosed HIV Patient.
    Lopez-Garcia A; Solan L; Alvarez B; Caballero JC; Cornago J; Pardo L; Diaz de la Pinta FJ; Cordoba R; Rodriguez-Pinilla M
    Medicina (Kaunas); 2023 Jul; 59(7):. PubMed ID: 37512086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.